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Abstract The redox enzyme violaxanthin de-epoxidase (VDE)
was found to be sensitive to pepstatin, a specific inhibitor of
aspartic protease. The inhibition was similar to that of aspartic
protease in that it was reversible and accompanied by the
protonation of the enzyme. Of the two peaks of VDE appearing
on anion exchange chromatography, VDE-I predominated at pH
7.2. On lowering the pH of the chromatography, VDE-I
decreased and VDE-II increased. Furthermore, re-chromatogra-
phy of either peak yielded both peaks. These results suggest that
VDE-I and VDE-II are interconvertible depending on pH, and
thus, they represent the de-protonated and protonated forms of
the enzyme, respectively. Presumably the protonation-induced
structural change of the enzyme is responsible for the interaction
with pepstatin, and also with substrate. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The xanthophyll cycle plays an important role in protection
of plants against excess light [1]. Only two enzymes are in-
volved in the cycle, violaxanthin de-epoxidase (VDE) and
zeaxanthin epoxidase [2]. The former catalyzes the de-epoxi-
dation of violaxanthin to zeaxanthin through the intermediate
antheraxanthin, and the latter catalyzes the reverse reaction.
VDE is located in the thylakoid lumen and is activated by the
acidi¢cation of the lumen by photosynthetic electron trans-
port. In contrast, zeaxanthin epoxidase is located on the stro-
mal surface of thylakoid membranes and functions irrespec-
tive of the lumenal pH. Thus, the reactions can proceed
separately in opposite directions. Since violaxanthin is a
light-harvesting pigment, while antheraxanthin and zeaxan-
thin function as energy-dissipating ones [3], this system serves
to regulate the energy supply to photosystem II.
In spite of extensive studies on the enzymatic properties and
sequence analysis [4^8], the reaction center of VDE has not
been identi¢ed to date. Generally, inhibitor study can help
reveal the reaction center type, but no active site-speci¢c in-
hibitors have been found for this enzyme; although dithio-
threitol is known to inhibit VDE, its action is not site-speci¢c
and the inhibition derives from alteration of the conformation
of the enzyme by cleavage of the multiple disul¢de bonds
[7,9]. In a previous study [9], we puri¢ed VDE from spinach
and showed that it was inhibited by pepstatin, an acetylated
pentapeptide that is known to be a speci¢c inhibitor of as-
partic protease [10]. This ¢nding suggested that the reaction
centers of VDE and aspartic protease have a common struc-
tural feature, but the inhibition of VDE has not been charac-
terized in detail. In the present study, we show that it is pH-
dependent and reversible, and related to the protonation of
VDE, which are characteristics also found in the inhibition of
aspartic protease.
2. Materials and methods
2.1. Materials
Spinach was purchased at a local market. Monogalactosyldiacylgly-
cerol (MGDG) was the product of Serdary Research Laboratories
(London, Ont., Canada). Violaxanthin was a gift from Dr. S. Takai-
chi of Nippon Medical School. Pepstatin A was obtained from Sigma
(St. Louis, MO, USA). Other chemicals were from Wako Pure Chem-
ical Industries (Osaka, Japan).
2.2. VDE reaction
VDE was extracted by sonicating spinach thylakoids in 50 mM
Tris^HCl (pH 7.5) and 1 mM MgCl2 as described previously [11].
VDE activity was assayed spectrophotometrically by monitoring
A505 minus A540 with a dual-wavelength spectrophotometer (UV-
2200; Shimadzu, Kyoto, Japan) at room temperature as follows. 5 Wl
of 13.2 mM MGDG (in ethanol) was placed in a sample tube, with
which 5 Wl of 0.66 mM violaxanthin (in ethanol) was mixed. To the
mixture, 1 ml of 50 mM CH3COONa^HCl (pH 4.8) and 50 Wl of
VDE sample were added in that order. The absorbance di¡erence
gradually rose during the course of the stabilization of the mixed
micelles of MGDG and violaxanthin in the aqueous solution. It
took about 10 min for the absorbance di¡erence to reach a plateau.
The reaction was started by adding 20 Wl of 0.55 M ascorbic acid. The
activity was calculated from the initial rate of increase of the absor-
bance di¡erence with the di¡erence absorption coe⁄cient of 63 mM31
cm31 [6]. One unit (U) of activity is de¢ned as 1 Wmol violaxanthin
de-epoxidized per minute.
2.3. Inhibition of VDE by pepstatin and restoration by pH 7.5
treatment
VDE extract (50 Wl) was mixed with the same volume of 12.5 mM
CH3COONa^HCl (pH 4.8), which resulted in a solution with a ¢nal
pH of 5.8. To the mixture, 2.7 Wl of pepstatin solution (usually, the
concentration was 11.4 mM to give a ¢nal concentration of 0.3 mM)
in dimethyl sulfoxide (DMSO) was added. This solution was well
mixed by repeated sucking and ejection with a micropipette (Pipet-
man; Gilson). After incubation of the mixture at 15‡C for 10 min, the
pepstatin-treated VDE was subjected to the assay. DMSO somewhat
decreased the activity by itself, but this e¡ect was negligible when
photosystem II membranes were used as substrate [9]. Thus, the e¡ect
of DMSO should be related to possible alteration of the structure of
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mixed micelles; violaxanthin without lipid cannot be the substrate of
VDE and the micellar structure of the substrate is essential for the
reaction [4,11]. In this study, the DMSO-treated sample was regarded
as the control to evaluate the inhibition by pepstatin.
For restoration of VDE, 20 Wl of 0.1 M K2HPO4 was added to the
pepstatin-treated sample to raise the pH to 7.5. The sample was well
mixed by repeated sucking and ejection with a micropipette. After
incubation at room temperature for 10 min, the sample was assayed.
2.4. Chromatography
To remove polyphenol oxidase whose degradation products parti-
ally overlap with the 43-kDa polypeptide of VDE on SDS^PAGE
[12], VDE extract from spinach thylakoids equivalent to 130 mg chlo-
rophyll was subjected to chromatography on an a⁄nity column re-
taining antibodies against dithiothreitol-sensitive tetrameric protease
(DSTP, the same as polyphenol oxidase) [13]. The £ow-through frac-
tion from the anti-DSTP column, which contained VDE, was sub-
jected to HiTrap SP chromatography in the presence of 0.1% (w/v)
Tween 20, as described previously [9]. The preparation from the Hi-
Trap SP column was divided into three portions and subjected to
anion exchange chromatography as described previously [9], but at
three di¡erent pHs. Brie£y, the sample was dialyzed against 20 mM
sodium phosphate (pH 7.2, 6.6 or 6.0) and 0.05% Tween 20; the
dialysate was then loaded on a Mono Q column (1 ml; Pharmacia,
Uppsala, Sweden) that had been equilibrated with the same medium.
After washing with the equilibration medium, the column was eluted
with 50 ml of a linear gradient of 0^0.3 M NaCl in 20 mM sodium
phosphate (at the respective pHs) and 0.05% Tween 20; since the
detergent interferes with the activity assay with mixed micelles [11],
the concentration was decreased from 0.1% in the previous study [9]
to 0.05%.
3. Results
3.1. VDE is inhibited by treatment with pepstatin
When VDE extract was treated with 0.3 mM pepstatin
under standard conditions followed by 10-fold dilution with
the assay medium, activity was inhibited by 95%, compared to
the control that had been treated with DMSO alone. In con-
trast, no inhibition was observed when 0.03 mM pepstatin
was provided with VDE that had been diluted with the assay
medium. Thus, we adopted the pretreatment system to ob-
serve the inhibition. In the pretreatment, at least 4 min passed
before the maximal inhibition was observed (Fig. 1A), sug-
gesting that pepstatin may not immediately bind to the en-
zyme. Based on this result, we chose a period of 10 min for
the pepstatin treatment. VDE was maximally inhibited by the
treatment at 0.3 mM pepstatin or above with half inhibition
at 0.12 mM pepstatin (Fig. 1B).
3.2. The inhibition by pepstatin is pH-dependent and reversible
E¡ects of pH were studied by treating VDE with 0.3 mM
pepstatin at di¡erent pHs, which was followed by the assay at
pH 4.8. The extent of the inhibition was almost the same in
the range of pH 3.7^5.8, while the inhibition dramatically
diminished when the treatment was performed at pH 7 or
above (Fig. 2A). This observation suggests that pepstatin
did not e¡ectively bind to de-protonated VDE; the enzyme
has been suggested to be de-protonated at neutral pH
[5,14,15]. To examine the reversibility of the inhibition, the
pepstatin-treated VDE was brought to pH 7.5 by adding a
small volume of 0.1 M K2HPO4 and incubated at room tem-
perature for 10 min. We expected that if pepstatin bound at
pH 5.8 was released at pH 7.5, the inhibitor could not e¡ec-
tively rebind to the enzyme even when assay medium of pH
4.8 was added thereafter. In fact, the activity was 70% re-
stored by the temporary pH rise (Fig. 2B), suggesting that
the inhibition is reversible. Restoration at pH 7.5 took more
than 5 min to reach the maximal level (Fig. 2B). This result
suggests that pepstatin was not immediately released from the
enzyme upon the pH 7.5 treatment.
3.3. Protonation-induced structural change of VDE
We showed in a previous study [9] that VDE separates into
two peaks, VDE-I and VDE-II, when subjected to anion ex-
change chromatography on Mono Q at pH 6.5 in the presence
of Tween 20. However, such heterogeneity of the VDE mol-
ecule has not been reported by other authors [6,12,16] who
performed similar chromatography at pH 7.2 in the absence
of detergent. From this apparent discrepancy, we hypothe-
sized that the molecular heterogeneity of VDE would derive
from the protonation of the enzyme. To examine this hypoth-
esis, we subjected VDE to Mono Q chromatography at vari-
ous pHs. In this experiment, the sample had been partially
puri¢ed so that no polypeptides overlapped on SDS^PAGE
with the 43-kDa VDE polypeptide (see Section 2). VDE-I
predominated when the chromatography was performed at
pH 7.2, but as the pH of the chromatography was lowered,
VDE-I decreased and VDE-II increased (Fig. 3). Further-
Fig. 1. Characterization of the inhibition of VDE by pepstatin. A:
Time course of pepstatin treatment. VDE extract was treated with
0.3 mM pepstatin at pH 5.8 at 15‡C for the designated periods. The
sample was 10-fold diluted with the assay medium for the reaction
at pH 4.8. The activity of the sample treated with DMSO for
10 min (10.0 mU/ml) was taken as 100%. B: E¡ect of pepstatin
concentration. VDE extract was treated with the designated concen-
trations of pepstatin under the standard conditions prior to the as-
say. The activity of the sample treated with DMSO (8.6 mU/ml)
was taken as 100%.
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more, when VDE-I was subjected to re-chromatography at
pH 6.0, not only VDE-I appeared but also VDE-II (Fig. 4).
Similarly, both peaks appeared when VDE-II was subjected to
re-chromatography at pH 7.2 (Fig. 4). These ¢ndings indicate
that VDE-I and VDE-II are interconvertible by pH change,
and thus represent the de-protonated and protonated forms of
VDE, respectively. It is likely that VDE undergoes a structur-
al change along with the protonation, which allowed the sep-
aration of the two forms by the chromatography (see Section
4). The VDE-I and VDE-II preparations showed the same
enzymatic properties [9] and it was also the case with respect
to the inhibition by pepstatin (data not shown). This fact
suggests that VDE-I and VDE-II re£ect the respective forms
upon binding to the column, but after elution, the two peaks
become enzymatically equivalent by equilibration between the
two forms at any given pH.
4. Discussion
In the present study, we characterized the inhibition of
VDE by pepstatin. To observe the inhibition, treatment of
VDE with a relatively high (sub-millimolar) concentration of
pepstatin was necessary. This ¢nding suggests that the a⁄nity
of the inhibitor to the enzyme is not so high upon binding.
However, the observation of inhibition after 10-fold dilution
of the treated enzyme suggests that once the binding is accom-
plished, the inhibitor is hardly released by dilution. Thus, the
interaction of VDE and pepstatin is not simple. We interpret
the result taking account of the molecular structure of VDE
proposed by Bugos et al. [8]. They indicated referring to the
deduced amino acid sequences of VDE that this enzyme has
Fig. 2. pH-dependent reversible inhibition of VDE by pepstatin. A:
E¡ects of pH upon pepstatin treatment. VDE extract was treated
with 0.3 mM pepstatin at the designated pHs at 15‡C for 10 min,
and then subjected to the assay at pH 4.8. To obtain the pH values
indicated in the ¢gure, 12.5 mM CH3COONa^HCl (pH 4.8) used in
the standard conditions (square) was replaced by 50 mM bu¡er
(circle), either CH3COONa^HCl (pH 3.0), CH3COONa^HCl (pH
4.0), CH3COONa^HCl (pH 5.0), MES^NaOH (pH 6.0), HEPES^
HCl (pH 7.0), or TAPS^NaOH (pH 8.0). The activity of the sample
treated with DMSO at pH 5.8 (5.2 mU/ml) was taken as 100%.
B: Time course of restoration of pepstatin-inhibited VDE at pH
7.5. VDE extract, which had been treated with 0.3 mM pepstatin
under the standard conditions, was incubated at pH 7.5 for the des-
ignated periods prior to the assay. The activity of the sample
treated with DMSO under the standard conditions but not incu-
bated at pH 7.5 (9.1 mU/ml) was taken as 100%.
Fig. 3. Separation of VDE-I and VDE-II on anion exchange chro-
matography at di¡erent pHs. A: The £ow-through fraction from
the anti-DSTP column (see Section 2) was subjected to anion ex-
change chromatography on Mono Q at pH 7.2, 6.6 and 6.0. Frac-
tions with the activity were subjected to SDS^PAGE, and the gels
were stained with silver. The asterisk indicates the 43-kDa polypep-
tide of VDE. The ¢rst peak of VDE was designated VDE-I and the
second VDE-II [9]. B: Relative amounts of VDE-I and VDE-II at
di¡erent pHs. The relative amounts of VDE-I and VDE-II in the
total VDE were estimated from the results of A by image analysis
[9].
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an anti-parallel L-barrel structure, in which a lipocalin signa-
ture, which is indicative of binding of a small hydrophobic
molecule, is situated. This structure is consistent with their
previously proposed model, in which the VDE molecule has
a cavity formed by the protein folding, into which the sub-
strate enters [4]. If it is assumed that pepstatin enters the
cavity, the above discrepancy can be explained; it is hard to
enter and hard to exit. The ¢nding that neither the inhibition
by pepstatin nor the restoration at pH 7.5 occurred immedi-
ately upon the treatments is consistent with our interpretation.
The inhibition of VDE by pepstatin suggests that the reac-
tion centers of VDE and aspartic protease may have a com-
mon structural characteristic. However, this does not necessa-
rily imply that the active site of VDE is an aspartic acid
residue(s), considering the mechanism of inhibition proposed
above; pepstatin might interfere with the substrate entering
the cavity by binding to a site di¡erent from the active site.
Experiments to examine possible competition between the
substrate and pepstatin were performed, but no clear results
were obtained (Kawano and Kuwabara, unpublished). Fur-
ther study is needed to clarify how pepstatin inhibits VDE.
The pH dependence of the inhibition of VDE by pepstatin
appears to be similar to that of the rate constant of the initial
part of the activity in isolated pea chloroplasts [14] in that it
drastically changes in a narrow pH range around 6.0. Hill plot
analysis of the rate constant showed a Hill coe⁄cient of 5.3,
indicating a strong cooperativity with respect to protons [14].
The similarity suggests that the pH-dependent structural
change of VDE, which was inferred from the interconversion
between VDE-I and VDE-II (Fig. 4), a¡ects the interaction
with pepstatin as well as with substrate. Bratt et al. [5] sug-
gested that the protonation of the enzyme is related to the
cooperativity observed in the rate constant [14], as revealed by
the pH dependence of the binding of the enzyme to thylakoid
membranes, although the binding showed a slightly weak co-
operativity (Hill coe⁄cient) of 4 with an in£ection point at pH
6.6 instead of 6.0. Taking together the results in this study, it
is likely that the protonation of VDE causes not only the
increase in the bulk hydrophobicity of the enzyme but also
the structural change to more readily accept the substrate.
Note that pepstatin induces protonation of aspartic pro-
tease; the pKa of one of the two active site aspartic acid
residues in plasmepsin II increases from 4.7 to 6.5 through
interaction with pepstatin [17]. Thus, the a⁄nity of pepstatin
to the protease is extraordinarily enhanced by acidi¢cation of
the surrounding environment [18]. Whether pepstatin induces
the protonation of VDE should be examined in the future; it
could be an indication of the presence of a reactive amino acid
residue.
From the present study, we suggest that VDE-I and VDE-II
are related to the de-protonated and protonated forms of
VDE, respectively, based on the pH-dependent changes in
their relative amounts (Fig. 3) and on their interconvertibility
(Fig. 4). This assignment is apparently inconsistent with the
order of elution of the two peaks from the anion exchange
column [9] : VDE-I (de-protonated) was eluted earlier than
VDE-II (protonated) in a gradient of increasing NaCl concen-
tration. One might suspect that a hydrophobic interaction
between the protonated form and the column resin might
retard the elution. However, this situation seems unlikely
since the elution medium contained a neutral detergent Tween
20 at 0.1% to eliminate such hydrophobic interaction [9].
Thus, we speculate that the protonation of VDE may not
simply decrease the surface charge of the protein but also
cause a structural change that enhances the binding to the
anion exchange column resin. This hypothesized conforma-
tional change of VDE remains to be investigated in the future.
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Fig. 4. Re-chromatography of VDE-I and VDE-II obtained by
Mono Q chromatography. VDE-I and VDE-II preparations were
pooled and subjected to re-chromatography on Mono Q at pH 6.0
and pH 7.2, respectively. The asterisk indicates the 43-kDa polypep-
tide of VDE. Note that the re-chromatography is e¡ective in the
puri¢cation of VDE, as revealed by the polypeptide pro¢le.
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